CLEAR FUTURE INTENSIVE SPOT TREATMENT- salicylic acid lotion

Clear Future Intensive Spot Treatment by

Drug Labeling and Warnings

Clear Future Intensive Spot Treatment by is a Otc medication manufactured, distributed, or labeled by Arbonne International, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

Salicylic Acid 2%

Purpose

Acne Treatment

Uses

• for the treatment of acne.
• penetrates pores to reduce the number of acne pimples.
• dries and helps clear up acne pimples and allows skin to heal.

Warnings

For external use only

When using this product

• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
• avoid contact with eyes. If contact occurs, rinse thoroughly with water.

Stop use and ask a doctor if irritation or redness develops and lasts.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• cleanse the skin thoroughly before applying this product.
• cover the entire affected area with a thin layer one to three times daily.
• because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
• if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other information

STORAGE: 55°F–85°F

Inactive ingredients

water, isopentyldiol, glyceryl stearate SE, glycerin, butyrospermum parkii (shea) butter, glyceryl behenate, myristyl myristate, propanediol, hamamelis virginiana (witch hazel) water, isostearic acid, alpha-glucan oligosaccharide, bakuchiol, polyglyceryl-4 caprate, argania spinosa kernel oil, camellia sinensis seed oil, sesamum indicum (sesame) seed oil, serenoa serrulata fruit extract, salix alba (willow) bark extract, calendula officinalis flower extract, salvia officinalis (sage) leaf extract, rhamnose, saccharide isomerate, beta-sitosterol, glucose, glucuronic acid, tocopherol, niacinamide, xanthan gum, tridecyl salicylate, isodecyl salicylate, myristyl laurate, acrylates/C10-30 alkyl acrylate crosspolymer, aminomethyl propanol, cetyl alcohol, caprylyl glycol, benzethonium chloride, benzoic acid, chlorphenesin, phenoxyethanol.

Questions or comments?

1.800.272.6663

Monday–Friday
6 a.m.–6 p.m. Pacific time

SPL UNCLASSIFIED SECTION

Distributed by
Arbonne International, LLC
9400 Jeronimo Road
Irvine, CA 92618 USA

PRINCIPAL DISPLAY PANEL - 15 mL Tube Carton

ARBONNE®

CLEAR
FUTURE®

INTENSIVE ACNE
SPOT TREATMENT

SALICYLIC ACID 2%

0.5 fl. oz. / 15 mL

INGREDIENTS AND APPEARANCE

CLEAR FUTURE INTENSIVE SPOT TREATMENT 
salicylic acid lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 42508-210
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	2 mg  in 15 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
ISOPENTYLDIOL (UNII: 19NOL5474Q)
GLYCERYL STEARATE SE (UNII: FCZ5MH785I)
GLYCERIN (UNII: PDC6A3C0OX)
SHEA BUTTER (UNII: K49155WL9Y)
GLYCERYL DIBEHENATE (UNII: R8WTH25YS2)
MYRISTYL MYRISTATE (UNII: 4042ZC00DY)
PROPANEDIOL (UNII: 5965N8W85T)
HAMAMELIS VIRGINIANA TOP WATER (UNII: NT00Y05A2V)
ISOSTEARIC ACID (UNII: X33R8U0062)
.ALPHA.-GLUCAN OLIGOSACCHARIDE (UNII: S95658MI3W)
BAKUCHIOL (UNII: OT12HJU3AR)
POLYGLYCERYL-4 CAPRATE (UNII: 3N873UN885)
ARGAN OIL (UNII: 4V59G5UW9X)
CAMELLIA SINENSIS SEED OIL (UNII: O5R6DK2M9K)
SESAME OIL (UNII: QX10HYY4QV)
SAW PALMETTO (UNII: J7WWH9M8QS)
SALIX ALBA BARK (UNII: 205MXS71H7)
CALENDULA OFFICINALIS FLOWER (UNII: P0M7O4Y7YD)
SAGE (UNII: 065C5D077J)
RHAMNOSE (UNII: QN34XC755A)
SACCHARIDE ISOMERATE (UNII: W8K377W98I)
.BETA.-SITOSTEROL (UNII: S347WMO6M4)
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)
GLUCURONIC ACID (UNII: 8A5D83Q4RW)
TOCOPHEROL (UNII: R0ZB2556P8)
NIACINAMIDE (UNII: 25X51I8RD4)
XANTHAN GUM (UNII: TTV12P4NEE)
TRIDECYL SALICYLATE (UNII: AZQ08K38Z1)
ISODECYL SALICYLATE (UNII: S7097PFP4C)
MYRISTYL LAURATE (UNII: 58U0NZN2BT)
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)
CETYL ALCOHOL (UNII: 936JST6JCN)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
BENZETHONIUM CHLORIDE (UNII: PH41D05744)
BENZOIC ACID (UNII: 8SKN0B0MIM)
CHLORPHENESIN (UNII: I670DAL4SZ)
PHENOXYETHANOL (UNII: HIE492ZZ3T)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 42508-210-09	1 in 1 CARTON	04/01/2015
1		15 mL in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH FINAL	part333D	04/01/2015

Labeler - Arbonne International, LLC (021541164)